Insurance delays hinder access to vital bariatric surgery, despite IRDAI mandates, risking patient health and increasing ...
AstraZeneca’s IMFINZI® (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) has been approved in the US for the treatment of adult ...
Insurance hurdles delay bariatric surgery in India. OSSI survey shows patients face low awareness, high costs, and complex ...
MedPage Today on MSN
For Your Patients: Navigating Gastric Cancer Takes a Team Approach
Because treatment is highly individualized, the involvement of team members may vary. A typical gastric cancer team could ...
A survey reveals that insurance-related barriers are delaying necessary bariatric and metabolic surgeries for severe obesity ...
The HER2-positive gastric cancer market is set for sustained growth, driven by rising global disease prevalence and expanded HER2 testing that increases the number of patients eligible for targeted ...
People who have used GLP-1 medications—better known by their brand names like Ozempic, Mounjaro or Wegovy—have likely seen ...
Early-stage gastric cancer can be assessed more accurately using a new liquid biopsy tool that predicts lymph node metastasis ...
The evidence-based recommendations address how radiation therapy should be used across the spectrum of gastric cancer, from resectable locoregional to metastatic disease.
Cambridge: AstraZeneca has announced that Imfinzi (durvalumab) in combination with standard-of-care FLOT chemotherapy ...
ASTRO's new guidelines enhance radiation therapy strategies for gastric cancer, improving treatment outcomes and patient care ...
AstraZeneca’s Imfinzi approved in US as first and only perioperative immunotherapy for patients with early gastric and GEJ cancers: Cambridge, UK Thursday, November 27, 2025, 09 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback